Pulse Biosciences (NasdaqCM:PLSE) Q3 2025 Earnings Call November 05, 2025 04:30 PM ET Speaker2Hello, and thank you for standing by. My name is Mark, and I will be your conference operator today. At this time, I would like to welcome everyone to the Pulse Biosciences Q3 2025 earnings call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during this time, please press star followed ...

Key oral presentations highlight new safety, efficacy and workflow improvements data to optimize irrigation and support consistent procedural outcomes.YOKOHAMA, Japan, Nov. 3, 2025 /PRNewswire/ -- Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment1, today announced that new clinical and real-world data from its integrated-by-design VARIPULSE™ Platform in pulsed field ablation (PFA) procedures for atrial fibrillation (AF) will be presented at the Asia Pacific Heart Rhythm Society (AP ...

Key Takeaways STXS partners with CardioFocus to create a robotic PFA system for cardiac arrhythmia treatment.The collaboration merges robotic precision with advanced PFA technology for safer, faster ablations.STXS gains access to the expanding PFA market, enhancing its robotics portfolio and growth potential. Stereotaxis (STXS) recently partnered with CardioFocus to develop the first robotic Pulsed Field Ablation (PFA) system for treating cardiac arrhythmias. The collaboration brings together Stereotaxis’ r ...